Evidence map›Paper›PMID 24817972›Full record

ReviewInternational journal of clinical and experimental pathology2014

Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association.

Mitsuaki Ishida, Keiko Hodohara, Miyuki Yoshii, Hiroko Okuno, Akiko Horinouchi, Ayaka Shirakawa, Ayumi Harada, Muneo Iwai, Keiko Yoshida, Akiko Kagotani and 2 more

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Violet - Colored Inguinal Located Cutaneous Tumour?Open access Macedonian journal of medical sciences · 2018
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Mitsuaki IshidaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan ; Division of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Keiko HodoharaDepartment of Hematology, Shiga University of Medical Science Shiga, Japan.
Miyuki YoshiiDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Hiroko OkunoDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Akiko HorinouchiDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Ayaka ShirakawaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Ayumi HaradaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Muneo IwaiDivision of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Keiko YoshidaDivision of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Akiko KagotaniDivision of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Takashi YoshidaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Hidetoshi OkabeDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan ; Division of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the risk of malignant lymphoma in patients with atopic dermatitis (AD) remains controversial, an increased risk of malignant T-cell lymphoma in patients with AD has been reported. Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a relatively common distinct clinicopathological entity. However, occurrence of C-ALCL in patients with AD has been rarely reported. Herein, we describe the 5(th) reported case of C-ALCL occurring in a patient with AD and review the clinicopathological features. A 30-year-old Japanese male with a long-standing history of AD presented with a gradually enlarged nodular lesion in the right abdominal wall, which had spontaneously regressed without therapy. Two years later, multiple nodular lesions appeared in his trunk, and swelling of multiple lymph nodes was also detected. Histopathological studies demonstrated diffuse proliferation of large-sized lymphocytes with large convoluted nuclei containing conspicuous nucleoli and relatively rich cytoplasm in the skin and lymph node. Immunohistochemically, these lymphocytes were positive for CD30, CD8, and MUM1, and negative for CD3, CD4, and ALK1. Accordingly, a diagnosis of primary C-ALCL was made. The patient died of disease after various courses of chemotherapy. Our clinicopathological review revealed that the prognosis of C-ALCL occurring in patients with AD is poor because two of 5 patients died of disease. Therefore, albeit extremely rare, AD patients with C-ALCL should be monitored closely, and additional clinicopathological studies are needed to clarify the pathogenesis of C-ALCL occurring in patients with AD.

Indexed as

AdultComorbidityDermatitis, AtopicDrug TherapyFatal OutcomeHumansLymphoma, Large-Cell, AnaplasticMaleSkin Neoplasmsatopic dermatitislymph nodePrimary cutaneous anaplastic large cell lymphoma

Identifiers

PMID24817972
PMCPMC4014256
OpenAlexW1045077207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.